Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

An Oxford project using artificial intelligence to develop digital triage tools for mental health clinicians (CHRONOS) is one of 38 projects supported by the second wave of the NHS AI Lab's AI in Health and Care Award.

AI. Human head outline with circuit board inside.

Dr Andrey Kormilitzin, Department of Psychiatry, University of Oxford, said:

 

'CHRONOS will use AI technology to examine historical, anonymised medical notes to learn how care teams make decisions about treatment for individual patients. It will be capable of processing the long, detailed descriptions found in medical records to capture a “fingerprint” of an individual’s difficulties, symptoms and needs over time. CHRONOS will use this to suggest a treatment pathway alongside an explanation of its suggestion'.

The Award means that the NIHR Oxford Health Biomedical Research Centre (BRC) (a partnership between the University of Oxford and the Oxford Health NHS Foundation Trust) will be able to develop digital tools to make it easier for clinicians in secondary mental health care to rapidly identify the most appropriate treatments for their patients. This is the first time a mental health project has received the AI Award.

Professor Andrea Cipriani, PI on the project, Department of Psychiatry, University of Oxford, said:

 

'We are delighted to be one of the recipients of the Artificial Intelligence in Health and Care Award and look forward to developing CHRONOS to bring faster and more effective treatment to mental health patients in the NHS.'

The 38 trailblazing projects are backed by NHSX and the Accelerated Access Collaborative.

Health and Social Care Secretary, Matt Hancock, said:

 

'AI has the potential to completely revolutionise every part of how we approach healthcare, from how we diagnose diseases and the speed at which our doctors and nurses deliver treatments to how we support people’s mental health. The 38 projects we are backing reflect the UK’s trailblazing approach to innovation in the healthcare sector, and could help us take a leap forward in the quality of care and the speed of disease diagnoses and treatment in the NHS. Confronted with this global pandemic, our tech sector has risen to the challenge and upended how we do things through innovations to support people to test from home, complete remote consultations and diagnose issues safely.'

The Oxford project's team members include:

  • Professor Andrea Cipriani (Principal Investigator)
  • Dr Dan Joyce (Co-Investigator)
  • Dr Andrey Kormilitzin (Co-Investigator
  • Julia Harmer-Hunt (Patient and Public Involvement Co-Investigator)
  • Associate Professor Alejo Nevado-Holgado (Co-Investigator)
  • Dr Anthony James (Co-Investigator)

For more information about the NIHR Oxford Health BRC and to read the full press release.

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

How Mindfulness May Improve Body Satisfaction and Mood

New research from Emma Osborne, Research Assistant at the Centre for Research on Eating Disorders (CREDO) at the University of Oxford (and PhD Candidate at the University of Bath), and Dr Melissa Atkinson, University of Bath, investigated two ways in which mindfulness might improve body satisfaction and mood.

Review Highlights Risk Factors Associated with Violence in Schizophrenia

Researchers at Oxford University’s Department of Psychiatry have found that people with schizophrenia and related disorders are at higher-than-average risk of perpetrating violence, but that the overall risk remains low (less than 1 in 20 in women, and less than 1 in 4 for men over a 35-year period for violent arrests and crimes).

New Study will Investigate Brain Fog Symptoms in Post-Hospitalised COVID-19 Patients

C-Fog is a collaborative new study led by Oxford University researcher, Dr Maxime Taquet, which will investigate the reasons why brain fog or cognition problems affect patients after COVID-19 infection. With a better understanding of the mechanisms involved it may be possible to understand how to treat brain fog and help many thousands of people worldwide.

A New Experimental Study Investigated the Effects of Atorvastatin on Emotional Processing

Atorvastatin is one of a group of statins widely used to treat heart and blood vessel diseases. The medication works by lowering cholesterol in the blood. This new study shows that atorvastatin influences the way people experience certain emotions, giving us important insights about disorders such as anxiety and depression.

People with Long-COVID After Hospitalisation Face Limited Recovery After One Year

People who were hospitalised with COVID-19 and continued to experience symptoms five months later, show limited further recovery one year after hospital discharge, according to the latest results of a major national study looking at the long-term health impacts of COVID-19 on hospitalised patients.

The Effects of Social Media on Public Attention and Attitudes Towards COVID-19 Vaccines in the UK

A new study finds that media coverage of positive vaccine research can have a positive effect on overall social media sentiment, countering vaccine misinformation, but the effects wane over time.